Medicap Super Health
Natural health product licensed in Canada
- Other names
- Bi-Super H3, Orgen Super Health
- Licence holder
- Biowell Laboratories
- NPN or DIN-HM
- 80094518
- Status
- Active licence
- Licence date
- 19 September 2019
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 60 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 60 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Tyrosine Source : L-Tyrosine | 66.7 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 16.7 mg | Not calculated |
| 2-(diméthylamino)éthanol Source : Bitartrate de déanol | 66.7 mg | Not calculated |
| Biotine Source : Biotine | 166.7 mcg | 500.1 µg |
| Niacine Source : Niacine | 10.7 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 13.3 mg | 39,900 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 20 UI | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 20 mg | 60,000 µg |
| Vitamine B12 Source : Cyanocobalamine | 66.7 mcg | 200.1 µg |
| Magnésium Source : Oxyde de magnésium | 33.3 mg | 99,900 µg |
| Folate Source : Acide folique | 0.27 mg | Not calculated |
| Potassium Source : Chlorure de potassium | 7.3 mg | 21,900 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 13.4 mg AT | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 5 % Terpene lactones | Not specified | Not calculated |
| Phosphatidylserine Source : Lécithine de soja enrichie en phosphatidylsérine | 33.3 mg | Not calculated |
| Calcium Source : Calcium phosphate, monobasic, monohydrate | 2.5 mg | 7,500 µg |
| Acide para-aminobenzoïque Source : Acide para-aminobenzoïque | 33.3 mg | Not calculated |
Non-medicinal ingredients
Poly(sorbate) 80, Acide citrique, Dioxyde de titane, Cellulose, Silice, Carmine, Hypromellose, Stéarate de magnésium, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidants for the maintenance of good health. Helps (to) maintain/support immune function. Source of vitamins and minerals, factors in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80094518
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ginkgo biloba
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Phosphatidylserine
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.